Latest news with #NINGIResearch
Globe and Mail
4 days ago
- Business
- Globe and Mail
Securities Fraud Investigation Into Marex Group plc (MRX) Announced – Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Marex Group plc ('Marex' or the 'Company') (NASDAQ: MRX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MAREX GROUP PLC (MRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On August 5, 2025, NINGI Research published a report alleging, among other things, that Marex 'has engaged in a multi- year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure.' Specifically, the report states that the Company has concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund it both controls and trades with and that it is using the fund to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income. On this news, Marex's stock price fell $2.33, or 6.2%, to close at $35.31 per share on August 5, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Charles Linehan, Esq., Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 Email: shareholders@ Telephone: 310-201-9150 (Toll-Free: 888-773-9224) Visit our website at Follow us for updates on LinkedIn, Twitter, or Facebook. Whistleblower Notice Persons with non-public information regarding Marex should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@ About Glancy Prongay & Murray LLP Glancy Prongay & Murray LLP ('GPM') is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation. GPM has been consistently ranked in the Top 50 Securities Class Action Settlements by ISS Securities Class Action Services. In 2018, GPM was ranked a top five law firm in number of securities class action settlements, and a top six law firm for total dollar size of settlements. With four offices across the country, GPM's nearly 40 attorneys have won groundbreaking rulings and recovered billions of dollars for investors and consumers in securities, antitrust, consumer, and employment class actions. GPM's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPM's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Business Wire
4 days ago
- Business
- Business Wire
Rosen Law Firm Encourages Marex Group plc Investors to Inquire About Securities Class Action Investigation
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Marex Group plc (NASDAQ: MRX) resulting from allegations that Marex may have issued materially misleading business information to the investing public. So What: If you purchased Marex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@ for information on the class action. What is this about: On August 5, 2025, during market hours, NINGI Research published a report entitled 'Marex Group plc: A Financial House of Cards.' In announcing the report, NINGI Research stated that, in its opinion, 'Marex has engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure. We have uncovered evidence suggesting Marex is a financial house of cards, with a balance sheet riddled with holes and financials that we believe are unreliable.' On this news, the price of Marex Group stock fell 7.6% on August 5, 2025. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome.
Globe and Mail
4 days ago
- Business
- Globe and Mail
Marex Group plc (MRX) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Marex Group plc ('Marex' or the 'Company') (NASDAQ: MRX) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MAREX GROUP PLC (MRX), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On August 5, 2025, NINGI Research published a report alleging, among other things, that Marex 'has engaged in a multi- year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure.' Specifically, the report states that the Company has concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund it both controls and trades with and that it is using the fund to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income. On this news, Marex's stock price fell $2.33, or 6.2%, to close at $35.31 per share on August 5, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Marex securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith 3070 Bristol Pike, Suite 112 Bensalem, Pennsylvania 19020 Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Yahoo
7 days ago
- Business
- Yahoo
Marex Group plc issues statement regarding NINGI Research report
LONDON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Marex Group plc ('Marex' or the 'Group'; NASDAQ: MRX), the diversified global financial services platform, provided the following response to the report that was published earlier today by NINGI Research, a short selling fund. Marex rejects this malicious report as a transparent effort to manipulate the share price to enable NINGI to profit from the short position it previously built. The report was published without any involvement by Marex. The report contains factual inaccuracies, misstatements, and misleading allegations. Marex is committed to the highest standards of integrity, managing its business in accordance with regulatory requirements in every jurisdiction where it operates. Marex reports its financial figures in accordance with international reporting standards (IFRS) and adheres to the highest standards of corporate governance. Marex will report its second quarter results on Wednesday August 13, where we look forward to the opportunity to update the market on our recent performance and respond to analyst questions. About Marex:Marex Group plc (NASDAQ: MRX) is a diversified global financial services platform providing essential liquidity, market access and infrastructure services to clients across energy, commodities and financial markets. The Group provides comprehensive breadth and depth of coverage across four services: Clearing, Agency and Execution, Market Making and Hedging and Investment Solutions. It has a leading franchise in many major metals, energy and agricultural products, with access to 60 exchanges. The Group provides access to the world's major commodity markets, covering a broad range of clients that include some of the largest commodity producers, consumers and traders, banks, hedge funds and asset managers. With more than 40 offices worldwide, the Group has over 2,400 employees across Europe, Asia and the Americas. For more information visit Enquiries please contact: Marex:Nicola Ratchford / Adam Strachan+44 778 654 8889 / +1 914 200 2508nratchford@ astrachan@ FTI Consulting US / UK+1 919 609 9423 / +44 777 611 1222marex@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-03-2025
- Business
- Yahoo
NINGI Research short Vita Coco, says Costco to terminate contract
In a recently published report, NINGI Research says it is short Vita Coco (COCO), saying it is 'nothing more than a one-trick pony grazing in a niche TAM.' 'The stock is hyped as a unique growth story in the 'Better for you' beverage segment, but in 2024 sales just grew 4.5% YoY (vs. category at 15.4%) and its market share has been falling since early 2023. Compounding the problem, we uncovered that Costco (COST), Vita Coco's largest private label customer, will ultimately terminate its contract with the company, despite having renewed their partnership in 2023. This decision will result in an estimated $90 million revenue shortfall for Vita Coco by the end of 2025 and position Costco as its strongest competitor. Vita Coco is suffering from structural internal deficiencies, such as undisclosed-related-party transactions and supply chain mismanagement. We believe the company focuses on misleading the markets while insiders offload stock,' the report reads. Shares of Vita Coco had dropped about 3% to $34.43 in morning trading. Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on COCO: Disclaimer & DisclosureReport an Issue Vita Coco expands line of Vita Coco Treats with Orange & Creme Vita Coco's Earnings Call Highlights Growth and Challenges Vita Coco Faces Financial Strain Amid Regulatory Compliance Challenges Vita Coco Reports Strong 2024 Financial Results Vita Coco price target raised to $38 from $34 at Goldman Sachs Sign in to access your portfolio
